|4/ASep 3, 4:43 PM ET

Arnold Susan Elizabeth 4/A

4/A · PhaseBio Pharmaceuticals Inc · Filed Sep 3, 2021

Insider Transaction Report

Form 4/AAmended
Period: 2021-07-12
Arnold Susan Elizabeth
VP, Preclinical and Chem.
Transactions
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2021-07-124,5190 total
    Exercise: $1.74From: 2015-07-12Exp: 2021-07-12Common Stock (4,519 underlying)
  • Exercise/Conversion

    Common Stock

    2021-07-12$1.74/sh+4,519$7,86327,760 total
Footnotes (3)
  • [F1]Amended to correct the transaction code for common stock acquired through stock options exercised in a transaction on July 12, 2021.
  • [F2]Amended to add a transaction for the exercise of stock options on July 12, 2021.
  • [F3]All shares underlying this option have vested.

Documents

1 file
  • 4
    wf-form4a_163070178763813.xml

    FORM 4/A